FGF21 and obesity due to melanocortin 4 receptor deficiency: In accordance with these findings, 12 weeks of FGF21 administration reduced body weight and TG levels and improved glucose tolerance, while two weeks of FGF21 treatment significantly reduced liver dysfunction in monkeys with HFD-induced obesity [42].